Loading
II
IMV Inc. (formerly Immunovaccine Inc.) Stock: price and insider trades · Canada
IMV Inc. (formerly Immunovaccine Inc.): what insiders have been doing
This page follows insider dealings at IMV Inc. (formerly Immunovaccine Inc.) as filed with SEDI. Nothing new has been filed by managers of IMV Inc. (formerly Immunovaccine Inc.) in twelve months, the latest record being from 7 October 2019.
Our records for IMV Inc. (formerly Immunovaccine Inc.) go back to 2018, with 110 purchases and 1 sale on the open market in total.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
142
Thresholds
n/a
Buy Volume
€792,991
110 ops. · all time
Sell Volume
€7,325
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 7 October 2019
Declarations142 total
5,000 shares@ CA$3.7949.7% of flowCommon SharesTSXSEDI:3435300
Canonical exit: 2 Jan 2020 (T+90)
1,600 shares@ CA$3.507.7% of flowCommon SharesTSXSEDI:3433901
Canonical exit: 1 Jan 2020 (T+90)
200 shares@ CA$3.491.0% of flowCommon SharesTSXSEDI:3433898
Canonical exit: 1 Jan 2020 (T+90)
600 shares@ CA$3.442.8% of flowCommon SharesTSXSEDI:3433895
Canonical exit: 1 Jan 2020 (T+90)
100 shares@ CA$3.480.5% of flowCommon SharesTSXSEDI:3433897
Canonical exit: 1 Jan 2020 (T+90)
2,500 shares@ CA$4.075.3% of flowCommon SharesTSXSEDI:3386616
Canonical exit: 19 Sept 2019 (T+90)
5,000 shares@ CA$4.2513.7% of flowCommon SharesTSXSEDI:3386624
Canonical exit: 19 Sept 2019 (T+90)
5,000 shares@ CA$4.045811.6% of flowCommon SharesTSXSEDI:3386575
Canonical exit: 19 Sept 2019 (T+90)
500 shares@ CA$3.5020.1% of flowCommon SharesTSXSEDI:3384810
Canonical exit: 12 Sept 2019 (T+90)
500 shares@ CA$3.4519.8% of flowCommon SharesTSXSEDI:3384812
Canonical exit: 12 Sept 2019 (T+90)
1,000 shares@ CA$3.8544.1% of flowCommon SharesTSXSEDI:3383484
Canonical exit: 11 Sept 2019 (T+90)
2,500 shares@ CA$4.977.9% of flowCommon SharesTSXSEDI:3360953
Canonical exit: 29 Jul 2019 (T+90)
3,500 shares@ CA$4.458.9% of flowCommon SharesTSXSEDI:3360404
Canonical exit: 25 Jul 2019 (T+90)
2,500 shares@ CA$4.555.8% of flowCommon SharesTSXSEDI:3360207
Canonical exit: 28 Jul 2019 (T+90)
100 shares@ CA$4.920.3% of flowCommon SharesTSXSEDI:3360208
Canonical exit: 28 Jul 2019 (T+90)
2,400 shares@ CA$4.936.0% of flowCommon SharesTSXSEDI:3360210
Canonical exit: 28 Jul 2019 (T+90)
2,000 shares@ CA$4.264.4% of flowCommon SharesTSXSEDI:3359794
Canonical exit: 25 Jul 2019 (T+90)
2,500 shares@ CA$4.425.7% of flowCommon SharesTSXSEDI:3359793
Canonical exit: 25 Jul 2019 (T+90)
500 shares@ CA$4.271.1% of flowCommon SharesTSXSEDI:3359795
Canonical exit: 25 Jul 2019 (T+90)
3,000 shares@ CA$4.106.3% of flowCommon SharesTSXSEDI:3359482
Canonical exit: 24 Jul 2019 (T+90)
2,000 shares@ CA$4.6255.9% of flowCommon SharesTSXSEDI:3357780
Canonical exit: 16 Jul 2019 (T+90)
4,600 shares@ CA$4.3312.6% of flowCommon SharesTSXSEDI:3356933
Canonical exit: 14 Jul 2019 (T+90)
2,714 shares@ CA$3.970.8% of flowCommon SharesTSXSEDI:3349299
Canonical exit: 30 Jun 2019 (T+90)
1,100 shares@ CA$3.980.3% of flowCommon SharesTSXSEDI:3349300
Canonical exit: 30 Jun 2019 (T+90)
2,500 shares@ CA$5.306.8% of flowCommon SharesTSXSEDI:3349672
Canonical exit: 1 Jul 2019 (T+90)
25 of 142 declarations
About IMV Inc. (formerly Immunovaccine Inc.)
IMV Inc. is a biopharmaceutical company focused on developing immunotherapeutic treatments for cancer and infectious diseases. Formerly known as Immunovaccine Inc., it is listed on the Toronto Stock Exchange.
